A significant shift is underway in how doctors treat low-risk prostate cancer across the United States, with new data showing a broad move away from aggressive overtreatment that can leave patients dealing with unnecessary side effects.

This encouraging trend reflects a growing medical consensus that not every cancer diagnosis demands immediate intervention. By being more thoughtful about which cases truly need treatment versus careful monitoring, doctors are helping patients avoid complications like incontinence and erectile dysfunction when their cancer poses minimal threat. Read the full story →

Today's takeaway: Smarter medicine means better outcomes—this shift toward precision treatment is exactly what patients need.